SCHEMBL24434601

SCHEMBL24434601

CC(C)(OCc1ccccc1)c1csc(NC(=O)c2cccn2Cc2ccccc2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
KCNH2 Q12809 1/20 0.47
SCN3A Q9NY46 4/20 0.46
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
NPC1 O15118 5/20 0.42
RAB9A P51151 5/20 0.42
POLB P06746 3/20 0.42
HPGD P15428 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
PKM P14618 1/20 0.42
PDE5A O76074 1/20 0.42
PDE1A P54750 1/20 0.42
PDE1B Q01064 1/20 0.42
PDE1C Q14123 1/20 0.42
TP53 P04637 3/20 0.42
ALDH1A1 P00352 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24434894 0.95 SCN3A (0.45) CYP1A2CYP2D6CYP2C9CYP2C19KCNH2
SCHEMBL24435435 0.88 MEN1 (0.57) CYP1A2CYP2D6CYP2C9CYP2C19KCNH2
SCHEMBL24435294 0.88 SCN3A (0.47) CYP1A2CYP2D6CYP2C9CYP2C19KCNH2
SCHEMBL24434828 0.86 NPC1 (0.43) CYP1A2CYP2D6CYP2C9CYP2C19KCNH2
SCHEMBL24435076 0.85 MEN1 (0.48) CYP1A2CYP2D6CYP2C9CYP2C19KCNH2
SCHEMBL24434983 0.83 SMN1; SMN2 (0.44) CYP1A2CYP2D6CYP2C9CYP2C19KCNH2
SCHEMBL24435033 0.81 SMN1; SMN2 (0.42) CYP1A2CYP2D6CYP2C9CYP2C19KCNH2
SCHEMBL24434680 0.81 SMN1; SMN2 (0.42) CYP1A2CYP2D6CYP2C9CYP2C19KCNH2
SCHEMBL24434845 0.80 SMN1; SMN2 (0.45) CYP1A2CYP2D6CYP2C9CYP2C19KCNH2
SCHEMBL24434537 0.80 SMN1; SMN2 (0.60) CYP1A2CYP2D6CYP2C9CYP2C19KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220153732-A1 PROTEIN SECRETION INHIBITORS ENODIA THERAPEUTICS SAS (FR) 2022-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153732-A1 PROTEIN SECRETION INHIBITORS SEC61B, SEC61A1, SEC61G CYP1A2 3277/4885CYP2D6 3197/4885CYP2C9 3349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.